当前位置: 首页 SCI期刊 SCIE期刊 医学 中科院2区 JCRQ1 期刊介绍(非官网)
Neoplasia

NeoplasiaSCIE

国际简称:NEOPLASIA  参考译名:瘤形成

  • 中科院分区

    2区

  • CiteScore分区

    Q2

  • JCR分区

    Q1

基本信息:
ISSN:1476-5586
E-ISSN:1476-5586
是否OA:开放
是否预警:否
TOP期刊:是
出版信息:
出版地区:UNITED STATES
出版商:Neoplasia Press
出版语言:English
出版周期:Monthly
出版年份:1999
研究方向:ONCOLOGY
评价信息:
影响因子:6.3
H-index:115
CiteScore指数:9.2
SJR指数:1.887
SNIP指数:1.225
发文数据:
Gold OA文章占比:98.62%
研究类文章占比:94.87%
年发文量:78
自引率:0.0208...
开源占比:0.9596
出版撤稿占比:0
出版国人文章占比:0.17
OA被引用占比:1
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Neoplasia期刊介绍

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.

期刊简介Neoplasia期刊介绍

《Neoplasia》自1999出版以来,是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2024年最新版)Neoplasia Cite Score数据

  • CiteScore:9.2
  • SJR:1.887
  • SNIP:1.225
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Cancer Research Q2 60 / 230

74%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Neoplasia 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 2区 ONCOLOGY 肿瘤学 2区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Neoplasia JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 48 / 322

85.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 45 / 322

86.18%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计
  • 国家/地区数量
  • USA132
  • CHINA MAINLAND68
  • GERMANY (FED REP GER)28
  • Japan15
  • Canada13
  • Taiwan13
  • England12
  • Italy12
  • Switzerland12
  • Australia11

本刊中国学者近年发表论文

  • 1、FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer

    Author: Tang, Qingyun; Liu, Cheng; Zhang, Shengwei; He, Lijiao; Liu, Yunyi; Wang, Jing; Zhao, Xiaoyan; Li, Xinzhe

    Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100863

  • 2、Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model

    Author: Wang, Jie; Sud, Shivani; Qu, Yanli; Li, Liantao; Zhang, Jiajie; Marron, David; Knape, Nicole Michelle; Kim, Isaiah James; Wagner, Kyle Thomas; Zhang, Tian; Zhao, Yuxia; Guo, Genyan; Wang, Andrew Z.

    Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100864

  • 3、The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science

    Author: Lilly, Jena, V; Rokita, Jo Lynne; Mason, Jennifer L.; Patton, Tatiana; Stefankiewiz, Stephanie; Higgins, David; Trooskin, Gerri; Larouci, Carina A.; Arya, Kamnaa; Appert, Elizabeth; Heath, Allison P.; Zhu, Yuankun; Brown, Miguel A.; Zhang, Bo; Farrow, Bailey K.; Robins, Shannon; Morgan, Allison M.; Nguyen, Thinh Q.; Frenkel, Elizabeth; Lehmann, Kaitlin; Drake, Emily; Sullivan, Catherine; Plisiewicz, Alexa; Coleman, Noel; Patterson, Luke; Koptyra, Mateusz; Helili, Zeinab; Van Kuren, Nicholas; Young, Nathan; Kim, Meen Chul; Friedman, Christopher; Lubneuski, Alex; Blackden, Christopher; Williams, Marti; Baubet, Valerie; Tauhid, Lamiya; Galanaugh, Jamie; Boucher, Katie; Ijaz, Heba; Cole, Kristina A.; Choudhari, Namrata; Santi, Mariarita; Moulder, Robert W.; Waller, Jonathan; Rife, Whitney; Diskin, Sharon J.; Mateos, Marion; Parsons, Donald W.; Pollack, Ian F.; Goldman, Stewart; Leary, Sarah; Caporalini, Chiara; Buccoliero, Anna Maria; Scagnet, Mirko; Haussler, David; Hanson, Derek; Firestein, Ron; Cain, Jason; Phillips, Joanna J.; Gupta, Nalin; Mueller, Sabine; Grant, Gerald; Monje-Deisseroth, Michelle; Partap, Sonia; Greenfield, Jeffrey P.; Hashizume, Rintaro; Smith, Amy; Zhu, Shida; Johnston, James M.; Fangusaro, Jason R.; Miller, Matthew; Wood, Matthew D.; Gardner, Sharon; Carter, Claire L.; Prolo, Laura M.; Pisapia, Jared; Pehlivan, Katherine; Franson, Andrea; Niazi, Toba; Rubin, Josh; Abdelbaki, Mohamed; Ziegler, David S.; Lindsay, Holly B.; Stucklin, Ana Guerreiro; Gerber, Nicolas; Vaske, Olena M.; Quinsey, Carolyn; Rood, Brian R.; Nazarian, Javad; Raabe, Eric; Jackson, Eric M.; Stapleton, Stacie; Lober, Robert M.; Kram, David E.; Koschmann, Carl; Storm, Phillip B.; Lulla, Rishi R.; Prados, Michael; Resnick, Adam C.; Waanders, Angela J.

    Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100846

  • 4、Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer

    Author: Gao, Yaqi; Zou, Tianhui; Xu, Pingping; Wang, Yingchao; Jiang, Yi; Chen, Ying-Xuan; Chen, Haoyan; Hong, Jie; Fang, Jing-Yuan

    Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100850

  • 5、A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity

    Author: Wang, Xueli; Han, Bo; Dou, Baokai; Gao, Lin; Sun, Feifei; Qi, Mei; Zhang, Jing; Hu, Jing

    Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100875

  • 6、Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients-Knowledge from two independent international studies

    Author: Zhou, Jian-Guo; Liang, Rui; Wang, Hai-Tao; Jing, Su-Han; Hu, Wei; Frey, Benjamin; Fietkau, Rainer; Hechth, Markus; Ma, Hu; Gaipl, Udo S.

    Journal: NEOPLASIA. 2023; Vol. 37, Issue , pp. -. DOI: 10.1016/j.neo.2023.100877

  • 7、Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors

    Author: Bai, Yongkan; Liu, Xiang; Zheng, Limin; Wang, Song; Zhang, Junli; Xiong, Shi; Zhang, Pengfei; Jiao, Zichen; Zhao, Gefei; Zhou, Chu; Pang, Jiaohui; Xu, Yang; Ou, Qiuxiang; Mao, Yuan; Zhang, Louqian

    Journal: NEOPLASIA. 2023; Vol. 38, Issue , pp. -. DOI: 10.1016/j.neo.2023.100888

  • 8、Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells

    Author: Shui, Yifang; Hu, Xin; Hirano, Hiroshi; Tsukamoto, Hirotake; Guo, Wen-Zhi; Hasumif, Kenichiro; Ijima, Fumihiro; Fujino, Masayuki; Li, Xiao-Kang

    Journal: NEOPLASIA. 2023; Vol. 39, Issue , pp. -. DOI: 10.1016/j.neo.2023.100893

投稿常见问题

通讯方式:STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169。